ZIM (NYSE) director sells 5,000 shares, $110K proceeds reported

Rhea-AI Filing Summary

ZIM reporting a Form 144 trade by Eyal Ben Amram: sold 5,000 ordinary shares on 12/23/2025 for $110,000. Shares outstanding were 120,465,908 as of 03/11/2026, provided here as context.

Insights

Corporate Governance Analyst

Small, routine insider disposition with context showing limited scale.

The filing records a 5,000-share sale by an affiliate on 12/23/2025 for $110,000. The transaction is a disposition reported under Form 144 and is presented as a single past sale.

Shares outstanding are listed as 120,465,908 as of 03/11/2026, which provides scale; the sale represents a small fraction of that total. Cash-flow treatment and any trading plan attribution are not stated in the excerpt.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	6000	173520.00	120465908	03/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/24/2019	Restricted Stock Units	Issuer			176976	01/24/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eyal Ben Amram 9 ANDREI SAKHAROV STREET P.O. BOX 15067 HAIFA L3 3190500	Ordinary	12/23/2025	5000	110000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did ZIM insider Eyal Ben Amram report on Form 144?

The filing shows Eyal Ben Amram sold 5,000 ordinary shares on 12/23/2025 for $110,000. This entry records a disposition under Form 144 and cites the sale amount and date as reported.

How large was the reported sale relative to ZIM's outstanding shares?

The sale was 5,000 shares versus 120,465,908 shares outstanding as of 03/11/2026. That outstanding figure is given in the excerpt and provides scale; the filing does not calculate the percentage.

Does the excerpt state whether the sale was part of a 10b5-1 plan?

The excerpt does not state a Rule 10b5-1 trading plan or similar arrangement. It only records the sale date, share count, and total proceeds; no pre‑arrangement language appears in the provided text.

Who received the cash proceeds from the reported sale?

The excerpt lists the sale and the proceeds amount of $110,000, but it does not specify the recipient of cash proceeds or whether proceeds went to the selling holder; cash‑flow treatment is not detailed in the excerpt.

Where can I find the official transaction date and amount for the Form 144 entry?

The filing excerpt cites the transaction date as 12/23/2025 and total proceeds as $110,000 for 5,000 ordinary shares. Those exact figures appear in the Form 144 content provided here.